Published in Lancet on September 22, 1984
Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs. Gut (1987) 2.40
Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut (2000) 2.06
The effectiveness of ranitidine in reducing gastric acid-secretion decreases with continued therapy. Br J Clin Pharmacol (1986) 1.28
Comparison of different strategies for treatment of duodenal ulcer. Br Med J (Clin Res Ed) (1985) 1.01
Effects of one year's treatment with ranitidine and of truncal vagotomy on gastric contents. Gut (1987) 0.99
Deaths from peptic ulceration. Br Med J (Clin Res Ed) (1985) 0.94
Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial. Br Med J (Clin Res Ed) (1987) 0.92
Low dose maintenance treatment with cimetidine in duodenal ulcer: intermediate-term results. Postgrad Med J (1986) 0.83
Initial therapy for bacterial meningitis. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ (1990) 0.80
Ranitidine 150 mg at night in the prevention of gastric ulcer relapse. Gut (1987) 0.79
Cigarette smoking and duodenal ulcer. Gut (1985) 0.79
Effect of bedtime ranitidine on overnight gastric acid output and intragastric pH: dose/response study and comparison with cimetidine. Gut (1987) 0.78
Morbidity and treatment in elderly patients surviving hospital admission with bleeding peptic ulcer. Gut (1995) 0.78
Ranitidine and sucralfate as maintenance therapy for gastric ulcer disease: endoscopic control and assessment of scarring. Gut (1989) 0.77
Maintenance treatment of duodenal ulceration: ranitidine 300 mg at night is better than 150 mg in cigarette smokers. Gut (1991) 0.76
Prognosis of chronic duodenal ulcer: a prospective study of the effects of demographic and environmental factors and ulcer healing. Gut (1987) 0.76
CMA will launch major strategic planning exercise, board decides. CMAJ (1989) 0.75
Gastroenterology in the armed forces. Gut (1989) 0.75
Peptic ulcer disease. Pathophysiology and current medical management. West J Med (1987) 0.75
The H2-receptor antagonist era in duodenal ulcer disease. Yale J Biol Med (1994) 0.75
Relapse of duodenal ulcer. Br Med J (Clin Res Ed) (1986) 0.75
Acid, motility, and ulcers: a comparison of cisapride with placebo in the prevention of duodenal ulcer relapse. Gut (1993) 0.75
CMA paper will discuss ethical use of organs from anencephalic donors. CMAJ (1990) 0.75
Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit. BMJ (1988) 0.75
A house call to the big house. CMAJ (1989) 0.75
Cimetidine, carbenoxolone and gastric mucus. Gut (1988) 0.75
The Sioux Lookout Program: "so many problems, so few physicians". CMAJ (1989) 0.75
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions. Am J Transplant (2014) 3.43
Mortality in patients with haematemesis and melaena: a prospective study. Br Med J (1979) 3.31
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Steatorrhea and malignant lymphoma. The relationship of malignant tumors of lymphoid tissue and celiac disease. Am J Dig Dis (1967) 3.12
Distribution of colorectal adenomas: implications for bowel cancer screening. Med J Aust (2000) 2.82
Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy (2012) 2.67
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia. Am J Gastroenterol (2000) 2.60
Value of a centralised approach in the management of haematemesis and melaena: experience in a district general hospital. Gut (1990) 2.49
Angiosarcoma of the liver in a vinyl-chloride worker. Lancet (1974) 2.45
Effect of secretin on serum gastrin as measured by immunoassay. Gastroenterology (1971) 2.40
Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet (1981) 2.29
Refractory duodenal ulcer. Gut (1984) 2.25
Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med (1997) 2.21
Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol (1992) 2.19
Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology (1983) 2.11
Imaging myocardial fiber architecture in vivo with magnetic resonance. Magn Reson Med (1995) 2.10
Penicillin-binding protein 2 genes of non-beta-lactamase-producing, penicillin-resistant strains of Neisseria gonorrhoeae. Mol Microbiol (1989) 2.09
Nutritional studies on the entrants to an old people's home, with particular reference to folic-acid deficiency. Br Med J (1965) 2.08
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther (2001) 2.04
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Influence of smoking on healing rate of duodenal ulcer in response to cimetidine or high-dose antacid. Gastroenterology (1981) 1.93
Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A (2001) 1.93
Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol (2001) 1.89
Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut (1997) 1.88
Campylobacter like organisms in duodenal and antral endoscopic biopsies: relationship to inflammation. Gut (1986) 1.88
Cirrhosis and hepatoma in alcoholics. Gut (1966) 1.86
An enzyme-linked immunosorbent assay for the serodiagnosis of Campylobacter pylori-associated gastritis. Scand J Gastroenterol Suppl (1988) 1.86
Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther (1997) 1.86
Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs. L1210 leukemia in mice. J Med Chem (1978) 1.85
Radioimmunoassay of conjugated cholyl bile acids in serum. Gastroenterology (1973) 1.81
Immunoglobulins in viral hepatitis and active alcoholic liver-disease. Lancet (1965) 1.81
Percutaneous endoscopic gastrostomy: a review of indications, complications and outcome. J Gastroenterol Hepatol (2000) 1.78
Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut (1975) 1.72
Serum gastrin in duodenal ulcer. I. Basal levels and effect of food and atropine. Gut (1971) 1.71
Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J (Clin Res Ed) (1982) 1.69
Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection. Am J Transplant (2007) 1.67
Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant (2007) 1.64
Cimetidine treatment of duodenal ulceration: short term clinical trial and maintenance study. Gastroenterology (1978) 1.60
Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med (1974) 1.58
Hypergastrinaemia in chronic renal failure. Br Med J (1972) 1.57
Heartburn: community perceptions. J Gastroenterol Hepatol (2000) 1.56
Serum gastrin in chronic gastritis. Br Med J (1971) 1.56
Comparison of tri-potassium di-citrato bismuthate tablets with ranitidine in healing and relapse of duodenal ulcers. Lancet (1985) 1.55
Clinical trial of different doses of 131-I in treatment of thyrotoxicosis. Br Med J (1967) 1.54
Early detection of protein depletion in alcoholic cirrhosis: role of body composition analysis. Gastroenterology (1993) 1.52
Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev (1999) 1.52
Effect of food on serum gastrin evaluated by radioimmunoassay. Gut (1971) 1.51
Does 40 mg omeprazole daily offer additional benefit over 20 mg daily in patients requiring more than 4 weeks of treatment for symptomatic reflux oesophagitis? Aliment Pharmacol Ther (1993) 1.51
Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond (2001) 1.49
Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet (1981) 1.49
Controlled trial of a carbenoxolone/alginate antacid combination in reflux oesophagitis. Curr Med Res Opin (1978) 1.46
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers. J Clin Gastroenterol (1986) 1.46
How can we reduce the incidence and mortality of colorectal cancer? Med J Aust (1997) 1.45
Double-blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut (1979) 1.43
Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology. N Engl J Med (1974) 1.42
Laboratory detection of ciprofloxacin resistant Neisseria gonorrhoeae. J Clin Pathol (1991) 1.40
Cimetidine in "chickenpox oesophagitis". Br Med J (1978) 1.39
Measurements of bone strain in the walking animal. Res Vet Sci (1969) 1.38
Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant (2011) 1.38
High-dose ranitidine in the treatment of duodenal ulcer. Am J Gastroenterol (1989) 1.38
A double-blind controlled trial of clofibrate in the treatment of diabetic retinopathy. Diabetes (1969) 1.35
Plasma disappearance of radioactivity after intravenous injection of labeled bile acids in man. Gastroenterology (1975) 1.34
Mixed-lymphocyte reaction as a measure of immunological competence of lymphocytes from patients with Crohn's disease. Gut (1974) 1.34
Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun (1997) 1.34
Evaluation of breast masses and axillary lymph nodes with [F-18] 2-deoxy-2-fluoro-D-glucose PET. Radiology (1993) 1.27
Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut (1989) 1.27
Serum gastrin in duodenal ulcer. II. Effect of insulin hypoglycaemia. Gut (1971) 1.27
Upper gastrointestinal endoscopy: its effects on patient management. Br Med J (1979) 1.26
Serum gastrin in duodenal ulcer. 3. Influence of vagotomy and pylorectomy. Gut (1972) 1.24
Metabolism of lithocholate in healthy man. II. Enterohepatic circulation. Gastroenterology (1975) 1.22
Radioimmunoassay of gastrin. The response of serum gastrin to insulin hypoglycaemia. Scand J Gastroenterol (1971) 1.22
Long-term cimetidine in duodenal ulcer disease. Dig Dis Sci (1979) 1.22
Crohn's disease in Blackpool--incidence and prevalence 1968-80. Gut (1985) 1.21
Intermittent treatment of duodenal ulcer with cimetidine. Br Med J (1980) 1.20
Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates. Am J Transplant (2011) 1.20
Relapse rate of duodenal ulcer after cessation of long-term cimetidine treatment: a double-blind controlled study. Dig Dis Sci (1980) 1.19
Serum gastrin and the antral mucosa in atrophic gastritis. Br Med J (1971) 1.19
Cellular hypersensitivity to mitochondrial antigens in diabetes mellitus. Clin Exp Immunol (1973) 1.19
Generic equivalence and non-equivalence of drugs. Lancet (1972) 1.18
Primary biliary cirrhosis: the prevalence of hypothyroidism and its relationship to thyroid autoantibodies and sicca syndrome. Gastroenterology (1980) 1.18
Effects of acidosis and alkalosis on surface skeletal muscle hydrogen ion activity. Surg Gynecol Obstet (1969) 1.17
Pathological effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart (2006) 1.16
Validity and sensitivity of an intravenous bile acid tolerance test in patients with liver disease. N Engl J Med (1975) 1.16
Effects of long-term cimetidine on serum gastrin in duodenal ulcer. Dig Dis Sci (1979) 1.16
Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention. Aliment Pharmacol Ther (2013) 1.15
Radioimmunoassay of gastrin: studies in pernicious anaemia. Gut (1971) 1.15
Systematic review: do we need a new gastro-oesophageal reflux disease questionnaire? Aliment Pharmacol Ther (2004) 1.15
Further studies of a model for the etiology of anomalies of tooth number and size in humans. Connect Tissue Res (2002) 1.13
Maintenance of remission of ulcerative colitis: a comparison between balsalazide 3 g daily and mesalazine 1.2 g daily over 12 months. ABACUS Investigator group. Aliment Pharmacol Ther (1998) 1.13
Dystrophia myotonica--a radiological survey. Br J Radiol (1967) 1.13
Overdosage of tricyclic antidepressants. A report of two deaths and a prospective study of 24 patients. Med J Aust (1972) 1.13
Metabolism of lethocholate in healthy man. I. Biotransformation and biliary excretion of intravenously administered lithocholate, lithocholylglycine, and their sulfates. Gastroenterology (1975) 1.12
Reduction in mortality from upper gastrointestinal haemorrhage. Med J Aust (1983) 1.12
Recent trends in hospital admissions and mortality rates for peptic ulcer in Scotland 1982-2002. Aliment Pharmacol Ther (2006) 1.12
Severe hypothermia as a result of barbiturate overdose complicated by cardiac arrest. Lancet (1968) 1.11
Cyanoacrylate in the treatment of gastric varices complicated by multiple pulmonary emboli. Intern Med J (2006) 1.11
Pyloric CLO in the human stomach. Med J Aust (1985) 1.09